1-7 of 7
Michal Mielnik
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Belantamab mafodotin (belamaf) in combination with bortezomib, lenalidomide, and dexamethasone (VRd) for patients (pts) with transplant-ineligible (TI) newly diagnosed multiple myeloma (NDMM): A focus on treatment efficacy and management/resolution of ocular events in the Phase 1 dreamm-9 study

Free
Saad Usmani, Michał Mielnik, Aránzazu Alonso Alonso, Al-Ola Abdallah, Mamta Garg, Wojciech Janowski, Youngil Koh, Chang-Ki Min, Enrique Ocio, Hang Quach, Karthik Ramasamy, Albert Oriol, Paula Rodriguez-Otero, Ricarda Garcia Sanchez, Irwindeep Sandhu, Katja Weisel, Chris Brawley, Miguel Murillo, Fernando Carreño, Jacqueline Egger, Morrys Kaisermann, Marek Hus
Journal: Blood
Blood (2025) 146 (Supplement 1): 5840.
https://doi.org/10.1182/blood-2025-5840
Published: 2025
Journal Articles

Real-world efficacy and safety of teclistamab in relapsed or refractory multiple myeloma: Results from 87 patients treated by the polish myeloma group

Free
Grzegorz Charlinski, Jacek Krzanowski, Dominik Gorzelak, Agata Tyczynska, Lukasz Szukalski, Magdalena Olszewska-Szopa, Pawel Steckiewicz, Sylwia Trzpiot, Agnieszka Druzd-Sitek, Jaroslaw Grzyb, Anna Kopinska, Agnieszka Szymczyk, Boguslaw Machalinski, Elzbieta Wiater, Michał Mielnik, Marek Rodzaj, Marek Hus, David Vesole, Artur Jurczyszyn
Journal: Blood
Blood (2025) 146 (Supplement 1): 5838.
https://doi.org/10.1182/blood-2025-5838
Published: 2025
Journal Articles

Etentamig plus pomalidomide-dexamethasone combination therapy in relapsed or refractory multiple myeloma: A phase 1b dose-escalation and safety expansion study

Free
Peter Voorhees, Anita D'Souza, Hang Quach, Sabine Gaerditz, Estrella Carrillo-Cruz, Michał Mielnik, Tomasz Wrobel, Matthew Pianko, Dickran Kazandjian, M Hasib Sidiqi, Valerio De Stefano, Cesar Rodriguez Valdes, Shonali Midha, Ariel Grajales-Cruz, Hideki Goto, Satoshi Ito, Claudio Cerchione, Ziyi Jin, Shane Lee, Akshanth Polepally, Sneha Rathi, Ross La Motte-Mohs, Kristin D'Amico, Thomas Doerr, Chetasi Talati, Leanne Lash Fleming, Linda Ho, Katja Weisel, Marek Hus, Joaquin Martinez-Lopez
Journal: Blood
Blood (2025) 146 (Supplement 1): 247.
https://doi.org/10.1182/blood-2025-247
Published: 2025
Journal Articles

Long-term responders from the Phase 3 dreamm-7 study of belantamab mafodotin plus bortezomib and dexamethasone vs daratumumab plus bortezomib and dexamethasone in Relapsed/Refractory multiple myeloma

Free
Vania Hungria, Pawel Robak, Marek Hus, Vera Zherebtsova, Christopher Ward, Phoebe Joy Ho, Roman Hajek, Kihyun Kim, Sebastian Grosicki, Hanlon Sia, Adam Bryant, Marcelo Pitombeira de Lacerda, Gracia Martinez, Anna Sureda Balarí, Michał Mielnik, Maureen Nichols, Jorge Mouro, Zeyad Khalaf, Hena Baig, Margaret Polinkovsky, Nick Pirooz, Sybil Varghese, Joe Lee, Lydia Eccersley, María-Victoria Mateos
Journal: Blood
Blood (2025) 146 (Supplement 1): 2262.
https://doi.org/10.1182/blood-2025-2262
Published: 2025
Journal Articles

Phase I Study of Belantamab Mafodotin in Combination with Standard of Care in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Dreamm-9 Updated Interim Analysis

Free
Saad Z. Usmani, Michal Mielnik, Mamta Garg, Irwindeep Sandhu, Al-Ola Abdallah, Youngil Koh, Albert Oriol, Hang Quach, Katja C. Weisel, Aranzazu Alonso Alonso, Enrique M Ocio, Wojciech Janowski, Chang-Ki Min, Karthik Ramasamy, Ricarda García Sánchez, Paula Rodríguez-Otero, Chris Brawley, Jacqueline L Egger, Morrys C Kaisermann, Marek Hus
Journal: Blood
Blood (2024) 144 (Supplement 1): 497.
https://doi.org/10.1182/blood-2024-198669
Published: 2024
Journal Articles

ABBV-383 Plus Daratumumab-Dexamethasone in Relapsed or Refractory Multiple Myeloma: A Phase 1b Dose-Escalation and Safety Expansion Study

Free
Cesar Rodriguez, Michal Mielnik, Dickran Kazandjian, Wojt Janowski, Michael S.Y. Low, Matthew Pianko, Junichiro Yuda, Carrie Van Der Weyden, Larry D Anderson, Jr., Rahul Banerjee, Laura Rosinol Dachs, Claudio Cerchione, Malin Hultcrantz, Anita D'Souza, Amandeep Godara, Ariel Grajales-Cruz, Ziyi Jin, Akshanth R Polepally, Aarif Ahsan, Shane Lee, Kristin D'Amico, Orlando Bueno, Chetasi Talati, Anders Erik Svensson, Leanne Fleming, Katja C. Weisel, Marek Hus, Peter M. Voorhees
Journal: Blood
Blood (2024) 144 (Supplement 1): 496.
https://doi.org/10.1182/blood-2024-205083
Published: 2024
Journal Articles

Belantamab Mafodotin, Bortezomib, and Dexamethasone Vs Daratumumab, Bortezomib, and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Overall Survival Analysis and Updated Efficacy Outcomes of the Phase 3 Dreamm-7 Trial

Free
Vania Hungria, Pawel Robak, Marek Hus, Vera Zherebtsova, Christopher Ward, Phoebe Joy Ho, Roman Hajek, Kihyun Kim, Sebastian Grosicki, Hanlon Sia, Adam Bryant, Marcelo Pitombeira de Lacerda, Gracia Aparecida Martinez, Anna Maria Sureda Balarí, Irwindeep Sandhu, Claudio Cerchione, Peter Ganly, Meletios Dimopoulos, Chengcheng Fu, Mamta Garg, Al-Ola Abdallah, Moshe E Gatt, Albert Oriol, Michele Cavo, Robert Rifkin, Tomoaki Fujisaki, Michał Mielnik, Nick Pirooz, Joe Lee, Astrid McKeown, Rachel Rogers, Hena Baig, Lydia Eccersley, Sumita Roy-Ghanta, Maria Victoria Mateos
Journal: Blood
Blood (2024) 144 (Supplement 1): 772.
https://doi.org/10.1182/blood-2024-200336
Published: 2024